histology study on piriton treatment for 10 day

Upload: lihun-wong

Post on 10-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    1/48

    (12) Group member names:

    Wong Li Hun D20091034877Wang Chiao Ching D20091034838

    Ngang Huey Chi D20091034861

    Yee Chin Tien D20091034824

    Lee Yian Ping D20091034823

    Chew Mei Ping D20091034816

    Mazatul azrin bin Rahman D20091034846Muhammad hafiz bin Kadir D20091034812

    Yee Hon Kit D20091034822

    Rio Raydy Anak Ujang D20091034835

    Mariani bt Zakaria D20091034650

    Ameera bt Yahya D20091034814

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    2/48

    INTRODUCTIONWe begin the experiment with different patter colour

    of mice which make us easier to identify it during theprocess of weighting. We used the treatment of 500mg

    piriton drugs for ten day in ad libitum. The mice were putsin a cage and places outside the corridor of the lab for tensday. we schedule the time to feed the mice. Also record themice weight changes and amount of piriton consumed eachday. After tens day we dissect the mice and we extract the

    organ that we needed and those organ are inserted inethanol 70% for weeks. We choose mice because its easierto obtain and easily handled so that we can conserveresources that we use such as the dosage of piriton due thesmall size of mice.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    3/48

    PROBLEM STATEMENT

    We find it is difficult to make sure that the mice wereconsumed same amount of piriton during the

    experiment. not all the organs that we extact is used inthe making of slides. The present of air bubbles withinthe organ make us difficult in the process of sliding.

    The origin of mice/body condition of mice before

    inducement of piriton.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    4/48

    PURPOSE OF STUDY

    y To study the effects of piriton in schedule time towardsthe organ of animals such as mice, to prepare animals

    tissue slide for comparison in terms of histology withnormal animal slide which include heart, lung, kidneyoesophagus, intestine, liver, ovary and uterus.Purpsose of study also is to enchance the knowledgeabout the piriton drugs which widely used intreatments.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    5/48

    SIGNIFICANCE OF PROJECT

    This project will be the prove that over usage of thisdrugs will lead to harmfulness of our healthy. It is also

    to make sure, that the drugs is safely used by control ofthe dosage of drugs. As piriton is a widely usedantihistaminic drug in human and veterinarymedicine.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    6/48

    RESEARCH LIMITATIONSy Our project will significant only in the mice that we

    used. The result may be different in different species or

    animals due to the reactions toward piriton may varyusing different method.

    y Time is also another factor as the period ofinducement of piriton is limited.

    yMoreover ,there is problem with equipment.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    7/48

    BRIEF LITERATURE REVIEW

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    8/48

    Mice are divided into several group. 1 group

    as the vehicle control. The other group aretreatened with higher dose of piriton.

    The group that treatened with piriton have a

    much lower survival rate in compare to thevehicle group.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    9/48

    y There are several effect that occur to the thyroid gland ofthe mice.

    They are thyroid gland follicular cyst,

    Thyroid gland follicular cell hyperplasia ,

    thyroid gland follicular cell adenoma.

    y A subcutaneous tissue tumors were found in male mice.

    y . Chlorpheniramine maleate had a proliferative effect in

    the thyroid gland of female mice, as shown by theincreased incidences of follicular cell cysts andhyperplasia in both low dose and high dose groups.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    10/48

    y The major route of excretion of chlorpheniramine or its

    metabolites is in the urine. In male rats orallyadministered 14C-chlorpheniramine maleate at doses of 2or 20 mg/kg, there was essentially no difference in thepercentage of urinary or fecal excretion of radioactivitybetween these dose levels.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    11/48

    Effect of piriton on the mobility of T lymphocyte

    y T lymphocyte mobility is low in subject with lowneutrophil mobility.

    y Histamine accelerates mobility of T lymphocytes in

    healthy subject and subject with diseases.y Piriton is an antihistamine drug which preventing the

    histamine to bind to specific receptor on the cell.

    y Without the histamine binding to the cell, the mobility

    of T lymphocyte through the membrane of the cell isgreatly reduced

    y This can bring a much worse effect toward the health ofthe mice

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    12/48

    Material & Methods

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    13/48

    MATERIAL:y Organ(liver, lungs, kidney, hearts, ovaries/testes,intestine) of 5 mices,

    piritonsolution, normal saline solution, Bouinss solution, ethanolsolution (70%,80%,95%,100%), toluene solution, paraffin solution,

    Xilen, pure alcohol, alcohol( 75%,80%,90%), distilled water,hematoksilin solution, 0.5% hydrochloric acid solution, 0.5%sodiumbicarbonate solution, scotts solution, Eosin, microtom and CanadaBalsam.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    14/48

    Methods:

    Fixation.

    Dehydration

    ClearingEmbeding

    Dissecting

    Staining

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    15/48

    RESULTS

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    16/48

    Cords of

    hepatocytes

    Portal Vein

    Liver sinusoids

    Normal Liver (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    17/48

    Protal Vein

    Branch of Bile Duct

    Protal Traid

    Branch of Hepatic Arteri

    Connective tissue

    septum

    Normal Liver (400X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    18/48

    Central vein

    Sinusoids

    Cords of

    hepatocytes

    Affected Liver (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    19/48

    Phagocytic

    Kupffer Cell

    Central Vein

    Sinusoids

    Affected Liver (400X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    20/48

    Sinusoid

    Phagocytic

    Kupffer Cell

    Affected Liver (400X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    21/48

    Sinusoids

    Cords ofhepatocytes

    Affected Liver (50X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    22/48

    Mucosa

    Villus

    Intestinal glands

    Submucosa

    Circular layer

    Longitudinal layer

    Serosa

    Normal Small Intestine (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    23/48

    Serosa

    Intestinal gland

    Muscularis

    externa

    Small Intestine l.s. (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    24/48

    Brunnergland

    Serosa

    Submucosa

    Lumen

    Intestinalgland

    Microvilli

    Small Intestine l.s. (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    25/48

    Intestinal glands

    Muscularis externa

    Lumen

    Mucosa

    Submucosa

    Serosa

    Large Intestine c.s (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    26/48

    Capsular space

    Distal convoluted tubule

    Renal corpuscle

    Proximal convoluted tubules

    Normal Kidney (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    27/48

    Kidney (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    28/48

    Renal orpuscle

    Proximal convoluted tubules

    Renal orpuscle

    Proximal convoluted tubules

    Mice Kidney (400X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    29/48

    Mice Kidney (400X)

    Glomerulus

    Arterioles

    Proximalconvoluted

    tubule

    Space within

    Bowmans

    capsule

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    30/48

    Aveolar sac

    SmoothMuscle

    Lumen

    Pseudostratifiedcolumnar epithelium

    Bronchus

    Vein

    Artery

    Normal Human Lung (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    31/48

    Bronchiole

    Vein

    Pseudostratified columnar

    epithelium

    Lumen

    Mucosa

    Lung (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    32/48

    Lung (100X)

    Vein

    Lumen

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    33/48

    Epicardium

    Myocardium

    Capillaries

    Normal Heart (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    34/48

    Myocardium

    Epicardium

    Blood in

    Lumen

    Endocardium

    Myocardium

    Heart (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    35/48

    NormalMice Ovary (100X)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    36/48

    Ovarian Vein

    Secondary follicles

    Primary oocyte

    Mature secondaryoocyte

    Corpus albicans

    Ovary (40X)

    Corpus luteum

    This section through an ovary shows follicles in various stages ofdevelopment.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    37/48

    Ovary (100X)

    GerminalEpithelium

    (surface)

    Tunica

    albuginea

    Secondary

    follicle

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    38/48

    Mice Ovary (100X)

    Secondary follicle

    Tunica albuginea

    Vein

    Modullarly region

    Corpus luteum

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    39/48

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    40/48

    PIRITONy contain active ingredient chlorpheniramine maleate.

    y effective antihistamine for all allergic conditions

    y If overdose will cause side effect such as hepatitis,urinary retention, arrhythmia and drowsiness.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    41/48

    THE EFFECT OF AFFECTED LIVERThese organs are implicated after the liver is

    affected.

    Heart

    Kidney

    The uterus & ovaries

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    42/48

    SUGGESTIONy Based on the research done by U.S. Department Of

    Health And Human Services, Public Health

    Service National Institutes of Health namedToxicology and Carcinogenesis Studies OfChlorpheniramine Maleate (CAS NO.113-92-8) INf344/N Rats and B6C3F1 Mice, they stated no

    microscopic pathologic effects were observed inmice in 16 days or 13 weeks studies.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    43/48

    y It is suggested to increase the period of studies up totwo years.

    y This is because no hyperactivity and hyperexcitabilityshown in 13 weeks studies

    y

    Besides, no significant positive trends or increases inthe incidences of neoplasms in either male or femalemice dosed with chlorpheniramine maleate for 103

    weeks.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    44/48

    The line chart showing the relationship of the

    weight of mice and period of studies

    0

    10

    20

    30

    40

    50

    60

    70

    80

    90

    100

    Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10

    Weight (g)

    Weight (g)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    45/48

    y Based on the line chart above, the average weight of the

    mice are increasing with accordance to period ofstudies, that is from day 1 till day 10.y From the chart, we can concluded that piriton didnt have

    any effect on the appetite of the mice.y The mice gained weight continueously since the start of

    experiment.y Other than that, there are other factors that may

    contributes to this result.y The mice lack of exercise since they are kept in a cage.y They dont have much space to move around compare to

    their original habitat.y The mice no need to compete for food since there are

    abundant supply.y They no need to go around and hunt for food.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    46/48

    The line chart showing the relationship of dosage(mg/g)

    use in mice against the period of study.

    0

    2

    4

    6

    8

    Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day

    Day 10

    Dosage (mg/g)

    Dosage (mg/g)

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    47/48

    y The dosage of piriton in the body of mice decreaseswith period of study.

    y This is because the mice are gaining weight each daybut the amount of piriton used in the experimentremain the same, that is 500mg each day.

    yWhen we divide the amount of piriton given with theweight of mice, we can see that the distribution ofpiriton less in each gram of the mice.

  • 8/8/2019 Histology Study on Piriton Treatment for 10 Day

    48/48

    THE END